Literature DB >> 15222631

Adrenocorticotrophic hormone retarded metabolism of low-density lipoprotein in rats.

N Xu1, M Hurtig, U Ekström, P Nilsson-Ehle.   

Abstract

In humans, treatment with adrenocorticotrophic hormone (ACTH) has well-documented plasma cholesterol lowering and low-density lipoprotein (LDL) lowering effects. Moreover, it has recently been demonstrated that ACTH directly inhibits apolipoprotein B expression and secretion in the HepG2 cell line. The aim of the present study was to demonstrate the effects of ACTH on lipid metabolism in the rat, and particularly on LDL metabolism. Rats were treated with porcine ACTH for 3 days and plasma lipid parameters were determined. Surprisingly, the total cholesterol level and LDL-cholesterol level were increased in plasma after ACTH administration, displaying an opposite effect of ACTH in humans. Furthermore, clearance and distribution of radiolabeled human LDL in different tissues were investigated in the rat after ACTH treatment. The clearance of radiolabeled LDL was slightly decreased after ACTH treatment suggesting that ACTH can inhibit LDL catabolism in the rat. Unlike previous observations performed in human hepatic cell cultures, there was no change in apoB expression in rat liver, or in apoE and apoM expression, after treatment with ACTH. This study clearly demonstrates that ACTH has species specificity differences in humans and in the rat.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15222631     DOI: 10.1080/00365510410005730

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  3 in total

Review 1.  Neuroendocrine control of appetite and metabolism.

Authors:  Eun-Seon Yoo; Jieun Yu; Jong-Woo Sohn
Journal:  Exp Mol Med       Date:  2021-04-09       Impact factor: 8.718

2.  Apolipoprotein M.

Authors:  Guanghua Luo; Xiaoying Zhang; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2004-10-04       Impact factor: 3.876

3.  Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells.

Authors:  Ye Yi-zhou; Cao Bing; Li Ming-qiu; Wang Wei; Wang Ru-xing; Rui Jun; Wei Liu-yan; Jing Zhao-hui; Ji Yong; Jiao Guo qing; Zou Jian
Journal:  Lipids Health Dis       Date:  2012-12-05       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.